Munich - Delayed Quote • EUR
Aytu BioPharma Inc (AY20.MU)
At close: May 17 at 8:06 AM GMT+2
Loading Chart for AY20.MU
DELL
- Previous Close
3.0200 - Open
2.8400 - Bid --
- Ask --
- Day's Range
2.8400 - 2.8400 - 52 Week Range
1.4000 - 3.0800 - Volume
50 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: AY20.MU
Performance Overview: AY20.MU
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
AY20.MU
6.77%
S&P 500
11.18%
1-Year Return
AY20.MU
68.05%
S&P 500
29.04%
3-Year Return
AY20.MU
96.79%
S&P 500
27.06%
5-Year Return
AY20.MU
99.04%
S&P 500
105.19%
Compare To: AY20.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2.8400
-5.96%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1071
+19.00%
Mkt Cap 11.647M
Industry Drug Manufacturers—Specialty & Generic
16.29
-0.06%
Mkt Cap 18.903B
Industry Drug Manufacturers—Specialty & Generic
Statistics: AY20.MU
Valuation Measures
As of 5/17/2024
Market Cap
15.06M
Enterprise Value
11.86M
Trailing P/E
--
Forward P/E
4.01
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.13
Enterprise Value/EBITDA
4.16
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: AY20.MU
Company Insights: AY20.MU
AY20.MU does not have Company Insights